Quantcast

Latest Menorrhagia Stories

2009-01-06 10:48:46

Experts estimate that 20 percent of women experience excessive or prolonged menstrual bleeding at some time during their lives, particularly as they approach menopause. A new, less invasive procedure called global endometrial ablation (GEA) preserves the uterus, while decreasing menstrual bleeding and shortening patients' recovery time. In an article published in the January issue of Obstetrics and Gynecology, Mayo Clinic researchers attempt to determine the percentage of women who do not...

2008-10-29 21:00:04

LAS VEGAS, Oct. 29 /PRNewswire/ -- At the annual meeting of the American Association of Gynecologic Laparoscopists (AAGL), ETHICON Women's Health & Urology today announced results of a seven-country study measuring the effects of uterine fibroids and associated symptoms on quality of life (QoL). Researchers found that one in five women suffer with symptomatic fibroids for more than 5 years before getting medical treatment. Further, despite diagnosis, more than one-third of women remain...

2008-10-23 09:00:10

Columbia Laboratories, Inc. (Nasdaq: CBRX) has signed an agreement with the Perinatology Research Branch (PRB) of the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) for collaboration in Columbia Laboratories' ongoing PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study of PROCHIEVE(R) 8% (progesterone gel) to reduce the risk of preterm birth in women with a short cervix at mid-pregnancy. The PRB is headed by Roberto Romero, MD. "The NICHD...

2008-09-29 09:00:15

Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced results from its Phase II study of vaginally-administered lidocaine, which the Company is investigating for the prevention and treatment of dysmenorrhea. No treatment currently exists to prevent dysmenorrhea. Seventy women with a history of moderate-to-severe dysmenorrhea participated in this first documented attempt to show prevention of uterine cramping and pain. This double-blind, placebo-controlled clinical trial used a...

2008-09-10 15:00:37

Reportlinker.com announces that a new market research report related to the Surgical material industry is available in its catalogue. World Uro-Gynecological Surgical Devices Market http://www.reportlinker.com/p092549/World-Uro-Gynecological-Surgical-Devices--Market.html This report analyzes the worldwide markets for Uro-Gynecological Surgical Devices in US$ Million. The major product segments analyzed are Urological Surgical Devices (Sling & Suspension Devices, & Other...

2008-09-09 09:00:09

ROCKLAND, Mass., Sept. 9 /PRNewswire/ -- Supermodel Beverly Johnson is on a mission to get women to Ask 4 questions and Tell 4 or more others about a health condition faced by up to 75 percent of all women in the U.S.(1): uterine fibroids. Although uterine fibroids are common, many women remain uninformed about this condition, and a majority wait up to a year before finding treatment, often despite pain, heavy bleeding and weight gain. Beverly did, and now she is sharing her story to ensure...

2008-09-09 09:00:08

WAYNE, N.J., Sept. 9 /PRNewswire/ -- Nina Garcia, judge of the Emmy-nominated series Project Runway, and the Step Up Women's Network are proud to announce the winner of the "YAZ(R): Step Up and Go Beyond" contest -- aspiring handbag designer Elayne Mayes of Green Village, New Jersey. Elayne's winning design will allow her to jumpstart her fashion design career with a $10,000 prize. Designed to empower women to go beyond what they thought was possible and achieve their career goals, the...

2008-09-08 09:00:52

Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that its third party data management consultants have confirmed that the results from the Company's recently completed Phase II clinical trial evaluating vaginal lidocaine for the prevention and treatment of dysmenorrhea (a condition typified by painful menstruation) will be available on or before September 29, 2008. The Company had previously expected top line data to be available at the end of August. Robert S. Mills,...

2008-09-04 03:00:07

PMS is that dreaded term that many women - and men - dread every month. The emotional rollercoaster is thought to affect about eight out of 10 women - however, many younger women don't realise they have it and are being treated for depression and anxiety instead. There are lifestyle and diet changes you can try that could make all the difference. We reveal how you too can help manage pre-menstrual monsters. ACCORDING to the latest research, 84 per cent of women wrestle with the...

2008-09-02 21:00:05

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. today announced positive safety and efficacy results from its third Phase II clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis. The PETAL study enrolled 252 patients, with a confirmed diagnosis of endometriosis, into three treatment groups; elagolix 150 mg once daily, elagolix 75 mg twice daily, or...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'